{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:35:50Z","timestamp":1768318550202,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012706","name":"University of Warmia and Mazury in Olsztyn","doi-asserted-by":"crossref","award":["15.610.008-300"],"award-info":[{"award-number":["15.610.008-300"]}],"id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.intimp.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T11:01:41Z","timestamp":1486724501000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of inhaled and systemic glucocorticoid treatment on CD4 + regulatory and effector T cells in a mouse model of allergic asthma"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-629X","authenticated-orcid":false,"given":"Monika","family":"Zu\u015bka-Prot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Ma\u015blanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.02.005_bb0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1398-9995.2009.02056.x","article-title":"Decreased FOXP3 protein expression in patients with asthma","volume":"64","author":"Provoost","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2017.02.005_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2332\/allergolint.12-OA-0492","article-title":"Decreased CTLA4+ and Foxp3+CD25highCD4+ cells in induced sputum from patients with mild atopic asthma","volume":"62","author":"Kawayama","year":"2013","journal-title":"Allergol. Int."},{"key":"10.1016\/j.intimp.2017.02.005_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-9255-11-22","article-title":"Decreased percentage of CD4+Foxp3+TGF-\u03b2+ and increased percentage of CD4+IL-17+ cells in bronchoalveolar lavage of asthmatics","volume":"11","author":"Barczyk","year":"2014","journal-title":"J. Inflamm."},{"key":"10.1016\/j.intimp.2017.02.005_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jaci.2004.04.048","article-title":"Fluticasone propionate increases CD4+CD25+ T regulatory cell suppression of allergen-stimulated CD4+CD25\u2212 T cells by an IL-10-dependent mechanism","volume":"114","author":"Dao Nguyen","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2011","key":"10.1016\/j.intimp.2017.02.005_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1465-9921-12-142","article-title":"Relationship between the anti-inflammatory properties of salmeterol\/fluticasone and the expression of CD4+CD25+Foxp3+ regulatory T cells in COPD","volume":"12","author":"Yang","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2017.02.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048816","article-title":"Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics","volume":"7","author":"Pace","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2017.02.005_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2017.02.005_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/83158","article-title":"A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation","volume":"2","author":"Das","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0050","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.4049\/jimmunol.178.8.4926","article-title":"Schnurri-2 controls memory Th1 and Th2 cell numbers in vivo","volume":"178","author":"Kimura","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.rvsc.2012.01.018","article-title":"In vitro effects of dexamethasone on bovine CD25+CD4+ and CD25\u2212CD4+ cells","volume":"93","author":"Ma\u015blanka","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.intimp.2017.02.005_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.rvsc.2014.02.006","article-title":"Effect of dexamethasone and meloxicam on counts of selected T lymphocyte subpopulations and NK cells in cattle \u2013 in vivo investigations","volume":"96","author":"Ma\u015blanka","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.intimp.2017.02.005_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2016.02.023","article-title":"I\u03baB kinase \u03b2 inhibitor, IMD-0354, prevents allergic asthma in a mouse model through inhibition of CD4+ effector T cell responses in the lung-draining mediastinal lymph nodes","volume":"775","author":"Ma\u015blanka","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0070","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.173.5.3432","article-title":"Vitamin D receptor-deficient mice fail to develop experimental allergic asthma","volume":"173","author":"Wittke","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI19095","article-title":"Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease","volume":"112","author":"Sondel","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2017.02.005_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.11.034","article-title":"Glucocorticoids decrease Treg cell numbers in lungs of allergic mice","volume":"747","author":"Olsen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.02.005_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(00)02581-2","article-title":"Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study","volume":"356","author":"Brutsche","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2017.02.005_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpba.2005.10.031","article-title":"Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids","volume":"41","author":"Taylor","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.intimp.2017.02.005_bb0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.2006.02592.x","article-title":"Effects of inhaled ciclesonide on circulating T-helper type 1\/T-helper type 2 cells in atopic asthmatics after allergen challenge","volume":"36","author":"Kawayama","year":"2006","journal-title":"Clin. Exp. Allergy"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T15:28:38Z","timestamp":1589729318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":19,"alternative-id":["S1567576917300607"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.02.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of inhaled and systemic glucocorticoid treatment on CD4+ regulatory and effector T cells in a mouse model of allergic asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}